Clarisyn
Every drug candidate deserves a fair question.
Clarisyn answers it through multi-agent reasoning, expert validation, and one decision-ready report.
Ask any biomedical question across any stage of drug discovery.
Clarisyn answers it thoroughly, traceably, from multiple angles.
Multi-agent analysis in progress.
Automated.
Multiple agents run in parallel.
Human-in-loop.
Experts can review and validate findings.
Your decision-ready structured report. In three layers.
Intelligence Report, highlighting the key insights and actionable takeaways.CYP3A4-mediated inhibition at clinical exposure levels presents a low but non-negligible DDI risk. Based on available in vitro and in vivo data, dose adjustment guidance for co-administered substrates is warranted prior to Phase I initiation.Agent consensus: 2 of 3 agents flagged DDI risk as clinically actionable. 1 agent rated risk as low-moderate pending in vivo confirmation.
Reasoning
Reasoning, scoring, and decision steps are shown in full for transparency.
Biological rationale and competitive intensity weighted across 7 criteria.
Each indication scored on a 1–5 scale per criterion, summed into a final weighted score.
Process
Intermediate steps are logged for full process transparency.
All reasoning steps are documented in a single file, with each agent's process clearly separated.
This analysis was built on 49 curated sources, synthesized across 200+ datasets spanning preclinical and clinical literature.
What sets R2H apart?
Every response draws from millions of academic papers, clinical trials, chemical databases, and protein structures.
General AI searches the web. Clarisyn searches the science. Structured, layered output shaped with scientists, built for scientists.
Is the hepatotoxicity signal observed in rats clinically relevant in humans?
Every response runs through a network of specialized agents, each checking the other's work. Not one model's opinion. A verified consensus.
30 minutes or up to 24 hours. Same question, different depth. Speed when you need it. Depth when it matters. You choose.
Invite teammates to review your report together. Or tap into a curated pool of professors, MDs, and PhD researchers for an independent perspective, without leaving the platform.
Can we rerun this with updated tox data?
Clarisyn doesn't stop at your question. It maps the full picture, with follow-up questions already answered.